MEETINGS - Seminar on Regulation, Requirements and Design of Drug Delivery Systems (UK) October 1999:
This article was originally published in Clinica
A seminar on Regulation, Requirements and Design of Drug Delivery Systems will be held in London on October 28. It will discuss European and US regulation of drug delivery systems both in terms of pharmaceuticals and medical devices. Practical design considerations and co-ordination issues will also addressed. Contact Management Forum for more details. Tel: +44 1483 570 099. Fax: +44 1483 536 424.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.